n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine has been researched along with etoposide in 1 studies
| Studies (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Trials (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Recent Studies (post-2010) (n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 14 | 0 | 0 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lindsay, GS; Nairn, LM; Wallace, HM; Woster, PM | 1 |
1 other study(ies) available for n(1)-ethyl-n-(11)-((cyclopropyl)methyl)-4,8-diazaundecane-1,11-diamine and etoposide
| Article | Year |
|---|---|
Cytotoxicity of novel unsymmetrically substituted inhibitors of polyamine biosynthesis in human cancer cells.
Topics: Acetyltransferases; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Division; DNA Fragmentation; DNA, Neoplasm; Enzyme Induction; Etoposide; Humans; Polyamines; Tumor Cells, Cultured | 2000 |